Small-cap defence suppliers rarely make headlines the way prime contractors do, yet it's often companies like Pennant International Group (LSE: PEN) that keep aircraft, vehicles and vessels operable long after they enter service.
Pennant has returned to view in mid-2026 after a run of contract news, culminating in a Canadian defence framework and a first sale through its Siemens partnership. What's caught commentators' attention specifically: the company's contracted order book now sits above its entire market capitalisation.
The Quick Version
- FY2025 revenue was £9.66m, down roughly 30%, with a statutory pretax loss of £2.5m but positive EBITDA of £1.64m.
- The order book stood at £23.3m as of the January 2026 update, up from £15.9m, and reportedly exceeds market capitalisation.
- A June 2026 framework with Canada's DND for Auxilium is worth up to C$35m (around £20m) over an extendable 11-year term.
- Pennant has paid no dividend since 2015 and gave no indication of reinstating one.
- Management guides to FY2026 revenue of around £13.0m and break-even adjusted pretax profit.
What Pennant Actually Does
Pennant designs training systems, provides integrated logistics and product support consultancy, and sells proprietary software — OmegaPS for through-life support planning and the Auxilium suite (GenS, Analyzer, R4i) for technical publications and training content. Since 2024, Pennant has consolidated these capabilities into Auxilium, distributed internationally via a July 2025 Siemens Digital Industries Software partnership.
Customers are concentrated among defence ministries and prime contractors: the UK Ministry of Defence, Boeing Defence UK (an Apache training upgrade programme) and, since June 2026, Canada's Department of National Defence. Roughly 60% of FY2025 revenue was recurring.
The 'Reset Year' Behind the Numbers
For the year ended 31 December 2025, Pennant reported revenue of £9.66m, down around 30% from £13.78m in FY2024. Management called 2025 a 'reset year' following a 2024 restructuring that included selling three commercial units and cutting roughly 30 roles for about £2m of annualised savings.
Reported EBITDA was positive at £1.64m, and the statutory pretax loss improved to £2.5m from £3.0m. On an adjusted basis, however, the pretax loss deteriorated to £1.9m from a near-breakeven £0.3m loss, reflecting the lower revenue base. H1 2025 revenue was down 39% year-on-year, implying H2 2025 was close to breakeven at the net level.
The Order Book Now Beats the Market Cap
The three-year order book stood at £23.3m as of January 2026, up from £15.9m, with £9.7m scheduled for 2026 delivery. Market commentary noted Pennant's roughly £13.3m market capitalisation sat below its £23.3m contracted order book — a discount to already-secured revenue, attributed to investors pricing in execution risk rather than a lack of demand.
The Canadian Deal and Siemens Partnership
A 12 June 2026 framework with Canada's DND for Auxilium is worth up to C$35m (around £20m) over an extendable eleven-year term — the largest disclosed contract in the company's recent history. Separately, the Siemens partnership produced its first Auxilium-GenS sale on 24 June 2026, giving Pennant access to Siemens' Teamcenter customer base.
Software ARR grew to £2.4m in FY2025, up 26%, guided to exceed £3.0m by end-2026.
A Much-Improved Balance Sheet
Net debt was reported at approximately £0.2m at 31 December 2025, down sharply from £2.3m a year earlier, aided by a September 2025 fundraise. Pennant raised £1.25m through an underwritten subscription at 21.5p, with proceeds reducing the company's HSBC overdraft and funding Auxilium investment and working capital.
No Dividend Since 2015
Pennant does not currently pay a dividend. Its last recorded distribution was 1p per share paid in December 2015. Given FY2025's statutory and adjusted pretax losses, and the stated priority of funding Auxilium development, working capital and debt reduction, retained cash is directed toward the business rather than distributed.
The Valuation Picture
Pennant shares closed at 28.50p, giving a market capitalisation of approximately £13.5m-£13.6m on 47.63 million shares, within a 52-week range of roughly 17.00p to 31.00p. Because the group reported a net loss for FY2025, a trailing P/E isn't meaningful. With EBITDA positive but statutory earnings negative, valuation is arguably better assessed against revenue and order-book coverage than earnings multiples for now.
Risks Worth Weighing
Customer concentration is the most prominent risk: a substantial share of revenue and order book rests on a small number of relationships — the UK MoD, Boeing Defence UK and now Canada's DND — so delay or non-renewal of any one programme could have an outsized impact. FY2025's steep revenue decline following the 2024 restructuring shows how milestone-based revenue recognition can produce sharp swings unrelated to underlying demand.
What to Watch Next
Watch Pennant's next trading update or interim results for progress against 2026 guidance of approximately £13.0m revenue and break-even adjusted pretax profit. Further RNS announcements on order-book conversion — particularly milestones under the Canadian DND framework — will matter for execution.
Bottom Line
Pennant International Group enters H2 2026 with a strengthened order book, a much-improved balance sheet after its September 2025 fundraise, and a landmark Canadian defence contract that could reshape its revenue mix. FY2025 was nonetheless difficult, with revenue down around 30%. The company pays no dividend and has given no indication of reinstating one, directing capital instead toward Auxilium development and debt reduction.

_11_17_2026_13_00_51_895454.jpg)




Please wait processing your request...